← Back to Search

Iliac Fascia Block (Ropivacaine) for Hip Injury

Phase 4
Waitlist Available
Led By Blake Bodendorfer, MD
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scheduled for arthroscopic labral repair with or without osteoplasty of the hip.
18 to 50 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks and 6 weeks
Awards & highlights

Study Summary

The purpose of this research is to determine differences in outcomes in patients who do, or do not, receive regional anesthesia (a fascia iliaca block) prior to undergoing hip arthroscopy with labral repair and/or debridement and osteoplasty for hip impingement

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks and 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Medication Requirement in PACU
Secondary outcome measures
Duration of PACU stay (mins)
Falls
Long Term Medication Requirements (daily log of medication usage in tablets of 5 mg oxycodone, morphine extended relief 15 mg, and/or indomethacin 75 mg)
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Iliac Fascia Block (Ropivacaine)Experimental Treatment2 Interventions
These patients will receive a preoperative iliac fascia block performed as a single shot in the standard fashion prior to hip arthroscopy with general anesthesia.
Group II: Control (Normal Saline Sham Injection)Placebo Group2 Interventions
These patients will receive a preoperative sham block of normal saline in the same fashion as a standard singl shot iliac fascia block prior to hip arthroscopy with general anesthesia.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ropivacaine
FDA approved
General Anesthesia
2006
Completed Phase 4
~4680

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
342 Previous Clinical Trials
126,532 Total Patients Enrolled
Union Memorial HospitalOTHER
1 Previous Clinical Trials
2,005 Total Patients Enrolled
Blake Bodendorfer, MDPrincipal InvestigatorGeorgetown University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Mar 2025